Several years later, another investigation group confirmed these data and revealed two galectin members (e.g., Gal-3 and -9) as being between the four most relevant parameters associated with more prolonged survival in metastatic melanoma patients [63]. This evidence concerns the gene LGALS3 and metastatic melanoma.